Obesity and kidney disease: hidden consequences of the epidemic

Csaba P Kovesdy, Susan L Furth, Carmine Zoccali, World Kidney Day Steering Committee, Csaba P Kovesdy, Susan L Furth, Carmine Zoccali, World Kidney Day Steering Committee

Abstract

Obesity has become a worldwide epidemic, and its prevalence has been projected to grow by 40% in the next decade. This increasing prevalence has implications for the risk of diabetes, cardiovascular disease and also for Chronic Kidney Disease. A high body mass index is one of the strongest risk factors for new-onset Chronic Kidney Disease. In individuals affected by obesity, a compensatory hyperfiltration occurs to meet the heightened metabolic demands of the increased body weight. The increase in intraglomerular pressure can damage the kidneys and raise the risk of developing Chronic Kidney Disease in the long-term. The incidence of obesity-related glomerulopathy has increased ten-fold in recent years. Obesity has also been shown to be a risk factor for nephrolithiasis, and for a number of malignancies including kidney cancer. This year the World Kidney Day promotes education on the harmful consequences of obesity and its association with kidney disease, advocating healthy lifestyle and health policy measures that makes preventive behaviors an affordable option.

Keywords: Chronic kidney disease; Kidney cancer; Nephrolithiasis; Obesity; Prevention.

References

    1. Kidney Int. 2004 May;65(5):1870-6
    1. Am J Clin Nutr. 2006 Feb;83(2):202-10
    1. Semin Nephrol. 2013 Jan;33(1):44-53
    1. Obesity (Silver Spring). 2011 Jun;19(6):1284-9
    1. Arch Intern Med. 2012 Nov 26;172(21):1644-50
    1. Eur Urol. 2012 Jul;62(1):160-5
    1. N Engl J Med. 2013 Jul 11;369(2):145-54
    1. Cell. 2010 Mar 19;140(6):883-99
    1. Lancet. 2000 Sep 9;356(9233):930-3
    1. Lancet Diabetes Endocrinol. 2015 Sep;3(9):704-14
    1. Am J Clin Nutr. 2011 Feb;93(2):413-21
    1. Am J Physiol. 1987 Dec;253(6 Pt 2):F1171-7
    1. Kidney Int. 2009 Jul;76(2):145-8
    1. J Am Coll Cardiol. 2009 Apr 14;53(15):1265-72
    1. Lancet Diabetes Endocrinol. 2014 May;2(5):417-26
    1. Obes Rev. 2010 May;11(5):389-98
    1. Am J Physiol Renal Physiol. 2002 Sep;283(3):F532-9
    1. Hypertension. 1995 Oct;26(4):610-5
    1. Lancet. 2014 Aug 30;384(9945):755-65
    1. JAMA. 2005 Jan 26;293(4):455-62
    1. Eur J Clin Nutr. 2002 Aug;56 Suppl 3:S42-5
    1. Am J Kidney Dis. 2008 Jul;52(1):29-38
    1. Am Rev Respir Dis. 1989 Jun;139(6):1435-8
    1. Nat Rev Nephrol. 2009 Dec;5(12):713-21
    1. Curr Opin Lipidol. 2010 Feb;21(1):38-43
    1. J Am Soc Nephrol. 2009 May;20(5):1140-8
    1. Arch Intern Med. 2005 Jul 25;165(14):1624-9
    1. Surg Obes Relat Dis. 2015 Mar-Apr;11(2):419-23
    1. Am J Transplant. 2010 Dec;10(12):2644-51
    1. Lancet Oncol. 2015 Jan;16(1):36-46
    1. Kidney Int. 2003 Nov;64(5):1838-44
    1. Cytokine Growth Factor Rev. 2014 Jun;25(3):257-71
    1. Hypertension. 2007 Oct;50(4):708-14
    1. Am J Physiol Gastrointest Liver Physiol. 2005 Feb;288(2):G292-9
    1. Clin J Am Soc Nephrol. 2012 May;7(5):735-41
    1. Nat Rev Cancer. 2004 Aug;4(8):579-91
    1. Kidney Int. 2004 Apr;65(4):1422-5
    1. Lancet. 2008 Feb 16;371(9612):569-78
    1. Kidney Int. 2005 Sep;68(3):1230-5
    1. Vasc Health Risk Manag. 2009;5(4):577-85
    1. Kidney Int. 2004 Jan;65(1):274-81
    1. J Am Soc Nephrol. 2001 Jun;12(6):1211-7
    1. Am J Kidney Dis. 2009 Oct;54(4):638-46
    1. Obes Res. 2004 Jan;12(1):106-13
    1. Am J Kidney Dis. 2005 Oct;46(4):587-94
    1. Am J Kidney Dis. 2007 May;49(5):581-91
    1. Hypertension. 2008 Feb;51(2):352-9
    1. J Am Soc Nephrol. 2011 Jun;22(6):1122-8
    1. Clin J Am Soc Nephrol. 2010 Dec;5(12):2258-68
    1. Kidney Int. 2008 Oct;74(8):994-7
    1. Nephrol Dial Transplant. 2016 Oct;31(10 ):1699-705
    1. J Am Soc Nephrol. 2006 May;17(5):1453-9
    1. Am J Kidney Dis. 2012 Nov;60(5):740-2
    1. Endocr Rev. 2012 Aug;33(4):547-94
    1. Ann Intern Med. 2006 Jan 3;144(1):21-8
    1. Am J Physiol. 1999 Dec;277(6 Pt 1):E971-5
    1. Contrib Nephrol. 2006;151:175-83
    1. BMC Public Health. 2015 May 08;15:475
    1. Eur Cytokine Netw. 2006 Mar;17(1):4-12
    1. Urol Res. 2006 Jun;34(3):193-9
    1. Ann Intern Med. 2016 Mar 1;164(5):305-12
    1. Lancet. 2015 Dec 5;386(10010):2287-323
    1. Hypertension. 2011 Nov;58(5):784-90
    1. J Am Coll Cardiol. 2001 Sep;38(3):789-95
    1. Am J Kidney Dis. 2003 Apr;41(4):733-41
    1. J Am Soc Nephrol. 2003 Sep;14(9):2366-72
    1. J Clin Invest. 2004 Dec;114(12):1752-61
    1. Am J Kidney Dis. 2016 Jan;67(1):62-9
    1. Am J Kidney Dis. 2005 Nov;46(5):871-80
    1. J Am Soc Nephrol. 1998 Sep;9(9):1645-52
    1. Cardiorenal Med. 2015 Dec;6(1):37-49
    1. Kidney Int. 2001 Apr;59(4):1498-509
    1. Clin J Am Soc Nephrol. 2016 Mar 7;11(3):528-35
    1. JAMA. 2016 Jun 7;315(21):2284-91
    1. Kidney Int. 2016 Jul;90(1):164-71
    1. Am J Kidney Dis. 2013 Aug;62(2):267-75
    1. Kidney Int. 2007 Jul;72(1):100-7
    1. Nephrol Dial Transplant. 2013 Nov;28 Suppl 4:iv82-98
    1. Diabetes. 1988 Dec;37(12):1595-607
    1. Nephrol Dial Transplant. 2007 Jun;22(6):1587-92
    1. Am J Kidney Dis. 2008 Jul;52(1):39-48
    1. J Am Soc Nephrol. 2006 Jun;17(6):1695-702
    1. J Epidemiol. 2014;24(6):444-51
    1. Arch Intern Med. 2005 Jan 10;165(1):55-61
    1. Kidney Int. 1996 Jan;49(1):200-8
    1. J Am Soc Nephrol. 2014 Sep;25(9):2088-96
    1. Blood Purif. 2005;23(1):57-63

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever